Patient-Reported Outcomes after Intensity-Modulated Proton Therapy for Oropharynx Cancer

Bahig, H; Gunn, BG; Garden, AS; Ye, R; Hutcheson, K; Rosenthal, DI; Phan, J; Fuller, CD; Morrison, WH; Reddy, JP; Ng, SP; Gross, ND; Sturgis, EM; Ferrarotto, R; Gillison, M; Frank, SJ

Author(s): Bahig, H; Gunn, BG; Garden, AS; Ye, R; Hutcheson, K; Rosenthal, DI; Phan, J; Fuller, CD; Morrison, WH; Reddy, JP; Ng, SP; Gross, ND; Sturgis, EM; Ferrarotto, R; Gillison, M; Frank, SJ;
Details: Publication Year 2021-06,Volume 8,Issue #1,Page 213-222
Journal Title: International Journal of Particle Therapy
Publication Type: Research article
Abstract: PURPOSE: To report patient-reported outcomes (PROs) derived from the Functional Assessment of Cancer Therapy-Head and Neck (FACT-HN) tool, in patients with oropharynx cancer (OPC) treated with intensity-modulated proton therapy (IMPT) in the context of first-course irradiation. MATERIALS AND METHODS: Patients with locally advanced OPC treated with radical IMPT between 2011 and 2018 were included in a prospective registry. FACT-HN scores were measured serially during and 24 months following IMPT. PRO changes in the FACT-HN scores over time were assessed with mixed-model analysis. RESULTS: Fifty-seven patients met inclusion criteria. Median age was 60 years (range, 41-84), and 91% had human papillomavirus-associated disease. In total, 28% received induction chemotherapy and 68% had concurrent chemotherapy. Compliance to FACT-HN questionnaire completion was 59%, 48%, and 42% at 6, 12, and 24 months after treatment, respectively. The mean FACT-General (G), FACT-Total, and FACT-Trial Outcome Index (TOI) score changes were statistically and clinically significant relative to baseline from week 3 of treatment up to week 2 after treatment. Nadir was reached at week 6 of treatment for all scores, with maximum scores dropping by 15%, 20%, and 39% compared to baseline for FACT-G, FACT-Total, and FACT-TOI, respectively. Subdomain scores of physical well-being, functional well-being, and head and neck additional concerns decreased from baseline during treatment and returned to baseline at week 4 after treatment. CONCLUSIONS: IMPT was associated with a favorable PRO trajectory, characterized by an acute decline followed by rapid recovery to baseline. This study establishes the expected acute, subacute, and chronic trajectory of PROs for patients undergoing IMPT for OPC.
Department(s): Radiation Oncology
PubMed ID: 34285948
Publisher's Version: https://doi.org/10.14338/IJPT-20-00081.1
Open Access at Publisher's Site: https://doi.org/10.14338/IJPT-20-00081.1
Terms of Use/Rights Notice: Refer to copyright notice on published article.

Creation Date: 2025-05-23 08:14:05

Last Modified: 2025-05-23 08:15:07